I love hearing your Excel questions. Post a comment on any video and I can help. I love solving data problems in Excel. I am an Excel MVP since 2005. I write about Excel in Strategic Finance magazine.
Exelixis EXEL announced encouraging results from an expansion cohort of the early to mid-stage study of its next-generation oral TKI, zanzalintinib, in combination with either Bristol Myers' BMY ...
Derek Archila, an analyst from Wells Fargo, maintained the Buy rating on Exelixis (EXEL – Research Report). The associated price target remains the same with $32.00. Derek Archila has given his Buy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback